US4863456A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Dosage form with improved delivery capability
Assignee: Alza Corp
•
Filing: 1988-02-08
•
Granted: 1989-09-05
•
Expires: 2008-02-08
Abstract
Abstract A dosage form is disclosed comprising a wall surrounding a compartment housing a first layer comprising a drug formulation, a middle layer comprising a hydrophobic composition, and a third layer comprising a hydrophilic composition.
Inventors
- 👤 Sally I. Stephens
- 👤 Patrick S. L. Wong
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 19:31
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
212 words
A dosage form for delivering a beneficial agent to the fluid environment of use, comprising: (a) a wall in at least a part a semipermeable composition permeable to the passage of an exterior fluid and substantially impermeable to the passage of a beneficial agent, which wall surrounds and forms: (b) a compartment; (c) a first layer comprising a beneficial agent in the compartment, which layer forms in situ a dispensable aqueous formulation comprising the beneficial agent with aqueous fluid that enters the compartment; (d) a third layer comprising hydrogel means for expanding and occupying space in the presence of fluid in the compartment; (e) a second layer pressed laminated into laminar arrangement between the first and third layer in the compartment, said second layer comprising a thickness of 1 to 7 mm and a permeability constant not more than about 1.0×10 -5 cm 2 /hr and being a separate and distinct layer comprising a different composition than the first and third layers, which second layer comprises a non-expandable hydrophobic composition that is a means for substantially preventing the migration of the beneficial agent from the first layer comprising the dispensable aqueous formulation into the third layer; and, (f) means in the wall connecting the exterior of the dosage form with the compartment.
Claim 2
Dependent Claim
212 words
A dosage form for delivering a beneficial agent to the fluid environment of use, comprising: (a) a wall in at least a part a semipermeable composition permeable to the passage of an exterior fluid and substantially impermeable to the passage of a beneficial agent, which wall surrounds and forms: (b) a compartment; (c) a first layer comprising a beneficial agent in the compartment, which layer forms in situ a dispensable aqueous formulation comprising the beneficial agent with aqueous fluid that enters the compartment; (d) a third layer comprising hydrogel means for expanding and occupying space in the presence of fluid in the compartment; (e) a second layer pressed laminated into laminar arrangement between the first and third layer in the compartment, said second layer comprising a thickness of 1 to 7 mm and a permeability constant not more than about 1.0×10 -5 cm 2 /hr and being a separate and distinct layer comprising a different composition than the first and third layers, which second layer comprises a non-expandable hydrophobic composition that is a means for substantially preventing the migration of the beneficial agent from the first layer comprising the dispensable aqueous formulation into the third layer; and, (f) means in the wall connecting the exterior of the dosage form with the compartment.
Claim 3
Dependent Claim
37 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the means connecting the exterior of the dosage form with the internal compartment comprises at least one passageway.
Claim 4
Dependent Claim
24 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the beneficial agent is chlorpheniramine.
Claim 5
Dependent Claim
37 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the means for connecting the exterior of the dosage form with the interior compartment is a microporous member.
Claim 6
Dependent Claim
46 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the means in the wall connecting the exterior of the dosage form with the compartment is a passageway pore formed by leaching a material from the wall.
References Cited (Backward Citations)
US3732865A
Cited
US3929132A
Cited
US3995632A
Cited
US4111202A
Cited
US4111201A
Cited
US4309996A
Cited
US4327725A
Cited
US4612008A
Cited
US4612186A
Cited
US4608048A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-09-04 | 1993-03-06 | 1993-09-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-09-04 | 1997-03-06 | 1997-09-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-09-04 | 2001-03-06 | 2001-09-05 | $7700.00 | Window Closed / Lapsed |